ClearBridge LLC (Maryland)’s Ligand Pharmaceuticals LGND Stock Holding History

ClearBridge LLC (Maryland)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-213,936	Closed	-$18.3M	–	186
2017 Q4	$18.3M	Buy	213,936 +20,262	+10%	+$1.76M	0.38%	71
2017 Q3	$16.4M	Sell	193,674 -25,328	-12%	-$2.01M	0.36%	73
2017 Q2	$16.6M	Buy	219,002 +20,254	+10%	+$1.42M	0.35%	67
2017 Q1	$13.1M	Buy	198,748 +68,817	+53%	+$4.53M	0.28%	74
2016 Q4	$8.24M	Buy	129,931 +23,676	+22%	+$1.49M	0.19%	114
2016 Q3	$6.76M	Hold	106,255	–	–	0.13%	110
2016 Q2	$7.91M	Buy	106,255 +5,178	+5%	+$384K	0.16%	90
2016 Q1	$6.75M	Sell	101,077 -217	-0.2%	-$13.2K	0.13%	102
2015 Q4	$6.85M	Buy	101,294 +3,687	+4%	+$228K	0.13%	99
2015 Q3	$5.21M	Buy	97,607 +9,971	+11%	+$605K	0.11%	111
2015 Q2	$5.52M	Buy	+87,636	New	+$4.78M	0.1%	107

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

ClearBridge LLC (Maryland)'s LGND Position: Q1 2018 in Review

ClearBridge LLC (Maryland) sold out of Ligand Pharmaceuticals (LGND) in Q1 2018, closing a stake of 213,936 shares — an estimated $18.3M sold.

ClearBridge LLC (Maryland) first reported a position in LGND in Q2 2015 and held it in 11 quarters. The position peaked at $18.3M in Q4 2017. 326 funds tracked by Wall St. Rank hold LGND as of Q1 2018.

ClearBridge LLC (Maryland) reported no remaining Ligand Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
ClearBridge LLC (Maryland) sold 213,936 Ligand Pharmaceuticals shares in Q1 2018, an estimated $18.3M.
ClearBridge LLC (Maryland) first reported a position in Ligand Pharmaceuticals in Q2 2015 and held it in 11 quarters.
ClearBridge LLC (Maryland)'s Ligand Pharmaceuticals position peaked at $18.3M in Q4 2017.
326 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2018.

Based on ClearBridge LLC (Maryland)'s 13F filing for Q1 2018, filed 15 May 2018.